A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)
Clinical trial NCT01313858 · COMPLETED
Trial details
- NCT number
- NCT01313858
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-04-01
- Primary completion
- 2015-09-01
- Enrollment
- 1613
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.